The search for genetic polymorphisms in the homocysteine/folate pathway that contribute to the etiology of human neural tube defects

<jats:title>Abstract</jats:title><jats:p>In this paper, we trace the history of current research into the genetic and biochemical mechanisms that underlie folate‐preventable neural tube defects (NTDs). The inspired suggestion by Smithells that common vitamins might prevent NTDs ignited a decade of biochemical investigations—first exploring the nutritional and metabolic factors related to NTDs, then onto the hunt for NTD genes. Although NTDs were known to have a strong genetic component, the concept of common genetic variance being linked to disease risk was relatively novel in 1995, when the first folate‐related polymorphism associated with NTDs was discovered. The realization that more genes must be involved started a rush to find polymorphic needles in genetic haystacks. Early efforts entailed the intellectually challenging and time‐consuming task of identifying and analyzing candidate single nucleotide polymorphisms (SNPs) in folate pathway genes. Luckily, human genome research has developed rapidly, and the search for the genetic factors that contribute to the etiology of human NTDs has evolved to mirror the increased level of knowledge and data available on the human genome. Large‐scale candidate gene analysis and genome‐wide association studies are now readily available. With the technical hurdles removed, the remaining challenge is to gather a sample large enough to uncover the polymorphisms that contribute to NTD risk. In some respects the real work is beginning. Although moving forward is exciting, it is humbling that the most important result—prevention of NTDs by maternal folic acid supplementation—was achieved years ago, the direct result of Smithells' groundbreaking studies. Birth Defects Research (Part A), 2009. © 2009 Wiley‐Liss, Inc.</jats:p>